Prostate carcinoma
|
0.170 |
Biomarker
|
disease |
BEFREE |
LncRNA Prostate cancer non-coding RNA (PRNCR1) is downregulated in many types of cancer.
|
31487296 |
2019 |
Prostate carcinoma
|
0.170 |
GeneticVariation
|
disease |
BEFREE |
Moreover, four prostate cancer-associated ncRNA 1 (PRNCR1, rs16901946 G/A, rs13252298 G/A, rs1016343 T/C, and rs1456315 G/A) SNPs were in association with cancer risk.
|
29802154 |
2018 |
Prostate carcinoma
|
0.170 |
GeneticVariation
|
disease |
GWASCAT |
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.
|
29892016 |
2018 |
Prostate carcinoma
|
0.170 |
AlteredExpression
|
disease |
BEFREE |
A long ncRNA (lncRNA) prostate cancer non-coding RNA 1 (PRNCR1) in the 8q24 has been reported to be upregulated in prostate cancer with a function of activating androgen receptor (AR).
|
26206497 |
2016 |
Prostate carcinoma
|
0.170 |
Biomarker
|
disease |
BEFREE |
The three variants are located within or near a number of prostate cancer-associated long noncoding RNAs (lncRNAs), including PRNCR1, PCAT1, and PCAT2.
|
26823525 |
2016 |
Prostate carcinoma
|
0.170 |
GeneticVariation
|
disease |
GWASCAT |
A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.
|
26034056 |
2015 |
Prostate carcinoma
|
0.170 |
Biomarker
|
disease |
BEFREE |
Thus, we conclusively demonstrate that PCGEM1 and PRNCR1 are not prognostic lncRNAs in prostate cancer and we refute suggestions that these lncRNAs interact in AR signaling.
|
24727738 |
2014 |
Prostate carcinoma
|
0.170 |
GeneticVariation
|
disease |
BEFREE |
These included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01).
|
25315430 |
2014 |
Prostate carcinoma
|
0.170 |
GeneticVariation
|
disease |
GWASCAT |
Evaluating genetic risk for prostate cancer among Japanese and Latinos.
|
22923026 |
2012 |
Prostate carcinoma
|
0.170 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.
|
23023329 |
2012 |
Prostate carcinoma
|
0.170 |
AlteredExpression
|
disease |
BEFREE |
Importantly, we show that this region was transcribed as a ∼13 kb intron-less long non-coding RNA (ncRNA), termed PRNCR1 (prostate cancer non-coding RNA 1), and PRNCR1 expression was upregulated in some of the PC cells as well as precursor lesion prostatic intraepithelial neoplasia.
|
20874843 |
2011 |
Prostate carcinoma
|
0.170 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study identifies new prostate cancer susceptibility loci.
|
21743057 |
2011 |
Prostate carcinoma
|
0.170 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.
|
20676098 |
2010 |
Prostate carcinoma
|
0.170 |
GeneticVariation
|
disease |
GWASCAT |
Multiple newly identified loci associated with prostate cancer susceptibility.
|
18264097 |
2008 |
Prostate carcinoma
|
0.170 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.
|
17401366 |
2007 |